Does Ranolazine Decrease Biomarkers of Myocardial Damage in Diabetics

NCT02611596 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

FED

Sponsor class

Conditions

Silent Myocardial Ischemia
Type 2 Diabetes

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Walter Reed National Military Medical Center